Ping Jiang

ORCID: 0000-0002-2466-0690
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Welding Techniques and Residual Stresses
  • Advanced Multi-Objective Optimization Algorithms
  • Advanced Welding Techniques Analysis
  • Probabilistic and Robust Engineering Design
  • Additive Manufacturing Materials and Processes
  • Optimal Experimental Design Methods
  • Aluminum Alloy Microstructure Properties
  • Manufacturing Process and Optimization
  • Laser Material Processing Techniques
  • Product Development and Customization
  • Business Process Modeling and Analysis
  • Service-Oriented Architecture and Web Services
  • Solidification and crystal growth phenomena
  • Aluminum Alloys Composites Properties
  • Collaboration in agile enterprises
  • Non-Destructive Testing Techniques
  • Microstructure and Mechanical Properties of Steels
  • Hydrogen embrittlement and corrosion behaviors in metals
  • Design Education and Practice
  • Neural Networks Stability and Synchronization
  • Advanced machining processes and optimization
  • High Entropy Alloys Studies
  • Metallurgy and Material Forming
  • Technology Assessment and Management
  • stochastic dynamics and bifurcation

Peking University
2025

Peking University Third Hospital
2025

Chengde Medical University
2025

Huazhong University of Science and Technology
2015-2024

Southwest Jiaotong University
2024

Hubei Polytechnic University
2015-2024

Shihezi University
2024

Shaoxing University
2024

Hunan Agricultural University
2022-2024

Xi'an University of Finance and Economics
2020-2023

Abstract The 2000 series aluminium alloys are qualified for widespread use in lightweight structures, but solidification cracking during fusion welding has been a long-standing issue. Here, we create zirconium (Zr)-core-aluminium (Al)-shell wire (ZCASW) and employ the oscillating laser-arc hybrid technique to control welding, ultimately achieve reliable crack-free of 2024 alloy. We select Zr wires with an ideal lattice match Al based on crystallographic information wind them by similar...

10.1038/s41467-024-45660-x article EN cc-by Nature Communications 2024-02-26

Sorafenib, an FDA-approved drug for advanced hepatocellular carcinoma (HCC), faces resistance issues, partly due to myeloid-derived suppressor cells (MDSCs) that enhance immunosuppression in the tumor microenvironment (TME). Various murine HCC cell lines and MDSCs were used a series of vitro vivo experiments. These included subcutaneous models, viability assays, flow cytometry, immunohistochemistry, RNA sequencing. analyzed chemotaxis, immunosuppressive functions, fatty acid oxidation (FAO),...

10.1186/s12943-025-02238-5 article EN cc-by-nc-nd Molecular Cancer 2025-01-28
Coming Soon ...